Galapagos NV - ADR

NASDAQ:GLPG  
55.47
+0.18 (+0.33%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)3.66B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$124.48 Million
Adjusted EPS-$1.57
See more estimates
10-Day MA$57.16
50-Day MA$59.53
200-Day MA$80.13
See more pivots

Galapagos NV - ADR Stock, NASDAQ:GLPG

Industriepark Mechelen Noord, Generaal de Wittelaan L11 A3, Mechelen, Brussels Region 2800
Phone: +32.1.534.29.00
Number of Employees: 1304

Description

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research & Development and Fee-for-Services segment. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.